The Norwood scale is the most widely used classification system for male androgenetic alopecia, describing seven stages of hair loss progression. The appropriate treatment plan differs meaningfully by stage — not because the pharmacological options change, but because the goals, urgency, and adjunct decisions differ. Here is a decision matrix built on the evidence at each stage.
Understanding the Norwood Scale
Norwood stages range from I (no significant loss, cosmetically insignificant recession) through VII (only a horseshoe of hair remaining above the ears and at the nape). Intermediate stages IIa, IIIa, IVa, and Va capture variations in frontal vs. vertex predominance. The scale is a visual classification, not a molecular assessment — progression varies dramatically in rate between individuals at the same stage.
Stage-by-Stage Decision Matrix
Norwood I–II: Minimal Recession
At these early stages, loss is cosmetically minor. The decision matrix centers on whether to start prophylactic treatment or observe. Key considerations:
- Strong family history of early significant loss + onset in 20s = strong argument for early pharmaceutical intervention to extend time before significant progression
- No strong family history, stable pattern for years = observation is defensible
- Finasteride at this stage can slow progression significantly; most men at NW II who treat maintain approximately that level for years
- There is no clinical disadvantage to starting finasteride early; the earlier treatment begins relative to follicle status, the more follicles are preserved
Norwood IIa–III: Active Progression, Moderate Loss
This is the stage where most men seek their first treatment, and where the evidence for intervention is clearest. Action plan:
- Primary: Finasteride 1mg daily (or dutasteride 0.5mg for stronger DHT suppression) — the DHT blocker is the foundational treatment
- Add: Topical minoxidil 5% once or twice daily, or oral minoxidil 1.25–2.5mg — complements the DHT blocker with a different mechanism
- Optional add: Microneedling 0.5–1.5mm, weekly or every 2 weeks — has good supportive evidence for improving minoxidil response
- Timeline: Expect 6–12 months before visible assessment; document baseline photography before starting
Norwood IV: Established Pattern, Crown Involvement
Crown involvement marks a stage where the "island" pattern begins to emerge. Full combination pharmacotherapy remains appropriate and can produce meaningful coverage improvement in follicles that are miniaturizing but not yet permanently lost. At this stage:
- If not already on combination therapy, start promptly — the "maybe I'll wait and see" phase is behind you
- Consider whether PRP (platelet-rich plasma) sessions complement the regimen — stronger evidence base than most regenerative options
- Begin thinking about transplant consultation — not necessarily to proceed immediately, but to understand what density could be restored surgically if pharmacological outcomes plateau
Norwood V–VI: Significant Coverage Loss
At this stage, pharmaceutical treatment alone rarely restores meaningful coverage — too many follicles are permanently miniaturized. The evidence-based action plan shifts:
- Continue finasteride + minoxidil to protect remaining native hair
- Serious consultation with a qualified hair transplant surgeon regarding FUE or FUT graft options
- Assess donor site quality — the quality and quantity of posterior donor follicles determines transplant candidacy and expected outcome
- Colombia transplant option: accredited clinics in Colombia offer FUE at significantly lower cost than North American clinics with comparable or equivalent outcomes, making the financial decision more accessible
Norwood VII: Horseshoe Pattern
At full Norwood VII, the donor supply is the limiting factor for any surgical restoration. The decision matrix here is highly individual — donor density, head shape, and personal priorities all vary. Pharmacological treatment maintains remaining hair. Transplant candidacy depends on donor quality. Non-surgical coverage (SMP, hairpiece) becomes a reasonable alternative to evaluate alongside surgical options.
The Single Most Underutilized Step
Across all stages, baseline documentation is the single most underutilized step. Men who start treatment without standardized photography have no objective way to assess response at 6 or 12 months — they're using subjective daily perception against a self-adjusting reference point. Four standardized photos today, filed with a date, is free and takes five minutes. It will be the most valuable diagnostic information you have in 12 months.